Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Clinical trial NCT00217542 · COMPLETED

Trial details

NCT number: NCT00217542
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Recurrent Renal Cell Cancer Stage III Melanoma Stage IV Melanoma Stage IV Renal Cell Cancer

Start date: 2005-07-01
Primary completion: 2008-07-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.